Perrigo Company PLC (PRGO) closed at $15.78 on October 30, 2026, down 0.8% from the previous close, on volume of 2,748,524 shares (30-day average 2,612,483).
Data as of October 30, 2026.
30-Oct-2026
Perrigo declares $0.29 dividend
Seeking Alpha News (Thu, 29-Oct 12:33 PM ET)
Perrigo Announces Quarterly Dividend
PRNewswire (Thu, 29-Oct 12:31 PM ET)
Perrigo to Divest Infant Formula Business, Refocus Strategy
TipRanks (Thu, 29-Oct 9:28 AM ET)
Perrigo to sell infant formula business to MeridianMade for $175M
Seeking Alpha News (Thu, 29-Oct 9:17 AM ET)
Perrigo Announces Agreement to Divest Infant Formula Business to MeridianMade
PRNewswire (Thu, 29-Oct 9:01 AM ET)
Analysts’ Top Healthcare Picks: Perrigo Company (PRGO), IQVIA Holdings (IQV)
TipRanks (Wed, 28-Oct 11:20 AM ET)
Perrigo Sets November 4 Date for Q3 2026 Results and 8:30 a.m. ET Conference Call
Market Chameleon (Wed, 21-Oct 7:51 AM ET)
Perrigo to Release Third Quarter 2026 Financial Results on November 4, 2026
PRNewswire (Wed, 21-Oct 8:31 AM ET)
Perrigo to Attend the Barclays Global Consumer Conference
PRNewswire (Thu, 27-Aug 8:31 AM ET)
Perrigo Targets Streamlined, Focused Growth Despite Revenue Dip and Margin Pressure in Q2 2026
Market Chameleon (Wed, 5-Aug 7:45 AM ET)
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Perrigo Company PLC trades on the NYSE stock market under the symbol PRGO.
As of October 30, 2026, PRGO stock price declined to $15.78 with 2,748,524 million shares trading.
PRGO has a beta of 2.49, meaning it tends to be more sensitive to market movements. PRGO has a correlation of 0.22 to the broad based SPY ETF.
PRGO has a market cap of $2.19 billion. This is considered a Mid Cap stock.
Last quarter Perrigo Company PLC reported $1 billion in Revenue and $.50 earnings per share. This beat revenue expectation by $15 million and exceeded earnings estimates by $.14.
In the last 3 years, PRGO traded as high as $34.60 and as low as $9.23.
The top ETF exchange traded funds that PRGO belongs to (by Net Assets): IJR, AVUV, VTI, IWM, VB.
PRGO has underperformed the market in the last year with a price return of -17.9% while the SPY ETF gained +12.3%. However, in the short term, PRGO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +55.9% vs +2.1% return in SPY. But in the last 2 weeks, PRGO shares have been beat by the market, returning -5.1% compared to an SPY return of -1.0%.
PRGO support price is $15.46 and resistance is $16.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRGO shares will trade within this expected range on the day.